View by Specialty

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

Emerging Diseases News

SPONSORED CONTENT
Save
SPONSORED CONTENT
November 01, 2024
4 min read
Save

Q&A: First case of bird flu in a US pig raises concern

Q&A: First case of bird flu in a US pig raises concern

The United States Department of Agriculture this week confirmed the first case of highly pathogenic H5N1 avian influenza in a U.S. pig, raising concerns about the potential health risk to humans.

SPONSORED CONTENT
October 31, 2024
2 min read
Save

COVID-19 vaccination rates plummet among nursing home personnel

COVID-19 vaccination rates plummet among nursing home personnel

There was a “marked decrease” in COVID-19 vaccine uptake among nursing home personnel last season, according to researchers, who attributed the decline to cost and the end of the CMS’s COVID-19 vaccine requirement in mid-2023.

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

SPONSORED CONTENT
October 29, 2024
2 min read
Save

Iowa resident dies of Lassa fever after returning from West Africa, officials say

Iowa resident dies of Lassa fever after returning from West Africa, officials say

An Iowa resident who traveled to West Africa has died of Lassa fever after returning home, Iowa health officials said.

SPONSORED CONTENT
October 29, 2024
3 min read
Save

Study raises questions about need for mpox booster doses

Study raises questions about need for mpox booster doses

LOS ANGELES — Neutralizing antibodies against mpox generated by the Jynneos vaccine were short lived — lasting less than a year — if patients had never received a smallpox vaccine as children, researchers said.

SPONSORED CONTENT
October 24, 2024
2 min read
Save

No increased autoimmune risk after omicron, delta COVID-19 in boosted patients

No increased autoimmune risk after omicron, delta COVID-19 in boosted patients

New diagnoses of autoimmune diseases were not overall more likely among vaccinated patients infected with omicron or delta variants of COVID-19, compared with those not infected, according to data published in JAMA Network Open.

SPONSORED CONTENT
October 23, 2024
2 min read
Save

CDC recommends 2nd COVID shot for some, lowering age for pneumococcal vaccination

CDC recommends 2nd COVID shot for some, lowering age for pneumococcal vaccination

A CDC advisory committee on Wednesday recommended that adults aged 65 years or older and anyone who is at least moderately immunocompromised receive a second dose of COVID-19 vaccine this season.

SPONSORED CONTENT
October 22, 2024
2 min watch
Save

VIDEO: Paxlovid effective for people with prior immunity, study shows

VIDEO: Paxlovid effective for people with prior immunity, study shows

LOS ANGELES — Paxlovid reduced the risk for severe COVID-19 hospitalization or death among people with existing immunity from a previous infection or vaccination, according to pooled trial data presented at IDWeek.

SPONSORED CONTENT
October 21, 2024
3 min watch
Save

VIDEO: A look at the year ahead with the SHEA president-elect

VIDEO: A look at the year ahead with the SHEA president-elect

LOS ANGELES — In a Healio video exclusive, the president-elect of the Society for Healthcare Epidemiology of America, or SHEA, gave an overview of the critical issues that health care epidemiologists will face in the coming year.

SPONSORED CONTENT
October 18, 2024
2 min read
Save

Detection of H5 in wastewater may have offered early bird flu warning

Detection of H5 in wastewater may have offered early bird flu warning

LOS ANGELES — Public health officials could have detected H5 influenza in wastewater days before highly pathogenic avian influenza was confirmed in cattle earlier this year, according to a study presented at IDWeek.

SPONSORED CONTENT
October 18, 2024
2 min read
Save

New data pave way for wider use of mpox vaccine in adolescents, researchers say

New data pave way for wider use of mpox vaccine in adolescents, researchers say

LOS ANGELES — Interim data from a phase 2 clinical trial of the Jynneos mpox vaccine showed that it is safe and generates an antibody response in adolescents that is similar to the response seen in adults, researchers reported.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails